© 1995 by Oxford University Press
Risk of Secondary Leukemia Following High Cumulative Doses of Etoposide During Chemotherapy for Testicular Cancer
CARSTEN BOKEMEYER, HANS-JOACHIM SCHMOLL, MARKUS A. KUCZYK, JõRG BEYER, and WOLFGANG SIEGERT
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Oncology..Etoposide
- Virology..Leukemia Virus
- Medicine..Treatment Options for Leukemia
- Oncology..Treatment Options for Testicular Cancer
- Medicine..Testicular Neoplasms
- Oncology..Epidemiology, Causes, and Risks of Leukemia
- Medicine..Neurotoxins
- Biophysics..Topoisomerases
- Physiology..Rats
- Oncology..Epidemiology, Causes, and Risks of Testicular Cancer
- Oncology..Treatment Options for Germ Cell Cancer
- Oncology..Topoisomerase Inhibitors
- Oncology..Anticancer Drugs
- Oncology..Leukemia
This article has been cited by other articles:
![]() |
W. Houck, R. Abonour, G. Vance, and L. H. Einhorn Secondary Leukemias in Refractory Germ Cell Tumor Patients Undergoing Autologous Stem-Cell Transplantation Using High-Dose Etoposide J. Clin. Oncol., June 1, 2004; 22(11): 2155 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Kagan, A. I. Kuzmenko, Y. Y. Tyurina, A. A. Shvedova, T. Matsura, and J. C. Yalowich Pro-oxidant and Antioxidant Mechanisms of Etoposide in HL-60 Cells: Role of Myeloperoxidase Cancer Res., November 1, 2001; 61(21): 7777 - 7784. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Travis, M. Andersson, M. Gospodarowicz, F. E. van Leeuwen, K. Bergfeldt, C. F. Lynch, R. E. Curtis, B. A. Kohler, T. Wiklund, H. Storm, et al. Treatment-Associated Leukemia Following Testicular Cancer J Natl Cancer Inst, July 19, 2000; 92(14): 1165 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Kagan, J. C. Yalowich, G. G. Borisenko, Y. Y. Tyurina, V. A. Tyurin, P. Thampatty, and J. P. Fabisiak Mechanism-Based Chemopreventive Strategies Against Etoposide-Induced Acute Myeloid Leukemia: Free Radical/Antioxidant Approach Mol. Pharmacol., September 1, 1999; 56(3): 494 - 506. [Abstract] [Full Text] |
||||
![]() |
M. A. Smith, L. Rubinstein, J. R. Anderson, D. Arthur, P. J. Catalano, B. Freidlin, R. Heyn, A. Khayat, M. Krailo, V. J. Land, et al. Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins J. Clin. Oncol., February 1, 1999; 17(2): 569 - 569. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



